These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1605783)

  • 21. The TPA controversy and the drug approval process. The view of the Cardiovascular and Renal Drugs Advisory Committee.
    Kowey PR; Fisher L; Giardina EG; Leier CV; Lowenthal DT; Messerli FH; Pratt CM
    JAMA; 1988 Oct; 260(15):2250-2. PubMed ID: 3139900
    [No Abstract]   [Full Text] [Related]  

  • 22. Recombinant tissue-type plasminogen activator in acute myocardial infarction: role of the critical care nurse.
    Kline EM
    Heart Lung; 1987 Nov; 16(6 Pt 2):779-86. PubMed ID: 2960639
    [No Abstract]   [Full Text] [Related]  

  • 23. [Future developments in thrombolytic therapy].
    Bode C; Runge MS
    Z Kardiol; 1993; 82 Suppl 2():187-90. PubMed ID: 8328201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trials with alteplase (rt-PA) in acute myocardial infarction.
    de Bono DP
    Adv Exp Med Biol; 1990; 281():377-82. PubMed ID: 2129374
    [No Abstract]   [Full Text] [Related]  

  • 25. [Vascular occlusion and myocardial infarct].
    Schaper W
    Z Kardiol; 1993; 82 Suppl 2():109-11. PubMed ID: 8328186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue plasminogen activator: a new thrombolytic agent.
    Crabbe SJ; Cloninger CC
    Clin Pharm; 1987 May; 6(5):373-86. PubMed ID: 3117481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing myocardial preservation after recombinant tissue plasminogen activator (rt-PA) in acute myocardial infarction.
    Rackley CE; Satler LF
    J Am Coll Cardiol; 1987 Dec; 10(6):1178-9. PubMed ID: 3119686
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipoprotein (a) levels do not influence the outcome of rt-PA therapy in acute myocardial infarction.
    Tranchesi B; Santos Filho R; Vinagre C; Caramelli B; Barbosa V; Gebara O; Belloti G; Pileggi F; Maranhão R
    Ann Hematol; 1991 Apr; 62(4):141-2. PubMed ID: 1827740
    [No Abstract]   [Full Text] [Related]  

  • 29. Community hospital experience with recombinant tissue plasminogen activator in acute myocardial infarction.
    Austin SM; Caro M; Gemmel D
    J Gen Intern Med; 1992; 7(2):187-90. PubMed ID: 1487767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genentech experience with rt-PA (activase).
    Grossbard EB
    J Am Coll Cardiol; 1987 Feb; 9(2):467. PubMed ID: 3100603
    [No Abstract]   [Full Text] [Related]  

  • 31. Tissue plasminogen activator and intracranial hemorrhage.
    Becker RC; Gore JM
    Ann Intern Med; 1990 Apr; 112(8):630. PubMed ID: 2109564
    [No Abstract]   [Full Text] [Related]  

  • 32. t-PA therapy in acute myocardial infarction.
    Giebel RA; Pavey SS; Bryant PP
    J Emerg Nurs; 1988; 14(4):206-13. PubMed ID: 3137387
    [No Abstract]   [Full Text] [Related]  

  • 33. New data clinch heart drug approval.
    Sun M
    Science; 1987 Nov; 238(4830):1031. PubMed ID: 3120310
    [No Abstract]   [Full Text] [Related]  

  • 34. Spontaneous hemothorax resulting from tissue plasminogen activator in a patient with ischemic stroke and unrecognized recent myocardial infarction.
    Kelmenson DA; Kurche JS; Geraci M
    Ann Am Thorac Soc; 2015 Jul; 12(7):1105-6. PubMed ID: 26203614
    [No Abstract]   [Full Text] [Related]  

  • 35. Spontaneous hepatic hemorrhage following treatment with tissue plasminogen activator.
    Roongsritong C; Buell JC
    Int J Cardiol; 1994 Sep; 46(2):182. PubMed ID: 7814170
    [No Abstract]   [Full Text] [Related]  

  • 36. Cholesterol embolization syndrome after intravenous tissue plasminogen activator for acute myocardial infarction.
    Arora RR; Magun AM; Grossman M; Katz J
    Am Heart J; 1993 Jul; 126(1):225-8. PubMed ID: 8322670
    [No Abstract]   [Full Text] [Related]  

  • 37. Bleeding complications and rt-PA.
    Schatz IJ
    J Am Coll Cardiol; 1988 Mar; 11(3):672. PubMed ID: 3125238
    [No Abstract]   [Full Text] [Related]  

  • 38. Announcement of protocol change in thrombolysis in myocardial infarction trial.
    Braunwald E; Knatterud GL; Passamani ER; Robertson TL
    J Am Coll Cardiol; 1987 Feb; 9(2):467. PubMed ID: 3100602
    [No Abstract]   [Full Text] [Related]  

  • 39. Hemorrhagic bursitis complicating treatment with recombinant tissue plasminogen activator.
    Perazella MA; Buller GK
    Am J Med; 1991 Oct; 91(4):440-2. PubMed ID: 1951393
    [No Abstract]   [Full Text] [Related]  

  • 40. Compartment syndrome of the triceps as a complication of thrombolytic therapy.
    Segal LS; Adair DM
    Orthopedics; 1990 Jan; 13(1):90-2. PubMed ID: 2105485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.